Medpace Holdings Total Assets 2014-2024 | MEDP

Medpace Holdings total assets from 2014 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Medpace Holdings total assets for the quarter ending September 30, 2024 were $2.084B, a 40.18% increase year-over-year.
  • Medpace Holdings total assets for 2023 were $1.657B, a 22.5% increase from 2022.
  • Medpace Holdings total assets for 2022 were $1.352B, a 18.52% decline from 2021.
  • Medpace Holdings total assets for 2021 were $1.66B, a 19.36% increase from 2020.
Medpace Holdings Annual Total Assets
(Millions of US $)
2023 $1,657
2022 $1,352
2021 $1,660
2020 $1,391
2019 $1,143
2018 $968
2017 $951
2016 $979
2015 $984
2014 $1,097
2013 $0
Medpace Holdings Quarterly Total Assets
(Millions of US $)
2024-09-30 $2,084
2024-06-30 $1,920
2024-03-31 $1,796
2023-12-31 $1,657
2023-09-30 $1,487
2023-06-30 $1,407
2023-03-31 $1,396
2022-12-31 $1,352
2022-09-30 $1,328
2022-06-30 $1,315
2022-03-31 $1,344
2021-12-31 $1,660
2021-09-30 $1,577
2021-06-30 $1,470
2021-03-31 $1,451
2020-12-31 $1,391
2020-09-30 $1,296
2020-06-30 $1,222
2020-03-31 $1,138
2019-12-31 $1,143
2019-09-30 $1,072
2019-06-30 $1,017
2019-03-31 $1,007
2018-12-31 $968
2018-09-30 $950
2018-06-30 $968
2018-03-31 $973
2017-12-31 $951
2017-09-30 $949
2017-06-30 $964
2017-03-31 $966
2016-12-31 $979
2016-09-30 $976
2016-06-30 $0
2016-03-31 $0
2015-12-31 $0
2015-09-30 $0
2014-12-31 $1,097
2013-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical Services $10.485B $1.886B
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $89.358B 11.09
Cencora (COR) United States $46.783B 17.59
DiDi Global (DIDIY) China $22.844B 0.00
Natera (NTRA) United States $20.907B 0.00
ICON (ICLR) Ireland $16.343B 14.56
Avantor (AVTR) United States $15.048B 22.56
Revvity (RVTY) United States $14.408B 25.03
BioMerieux (BMXMF) France $13.788B 0.00
Viatris (VTRS) United States $13.488B 4.15
Solventum (SOLV) United States $12.699B 0.00
CochLear (CHEOY) Australia $12.341B 0.00
Doximity (DOCS) United States $10.029B 59.03
EUROFINS SCIENT (ERFSF) Luxembourg $9.551B 0.00
HealthEquity (HQY) United States $8.876B 44.53
Charles River Laboratories (CRL) United States $8.361B 16.16
Sonic Healthcare (SKHHY) Australia $8.244B 0.00
Amplifon S.p.A (AMFPF) Italy $6.136B 31.28
Bausch + Lomb (BLCO) Canada $6.118B 28.46
Organon (OGN) United States $4.054B 4.09
Sotera Health (SHC) United States $3.676B 19.67
BrightSpring Health Services (BTSG) United States $3.230B 68.70
Alignment Healthcare (ALHC) United States $2.795B 0.00
Concentras Parent (CON) United States $2.691B 0.00
Surgery Partners (SGRY) United States $2.566B 29.26
Premier (PINC) United States $2.156B 11.22
PACS (PACS) United States $2.106B 0.00
Ardent Health Partners (ARDT) United States $2.013B 0.00
GeneDx Holdings (WGS) United States $1.909B 0.00
Progyny (PGNY) United States $1.788B 36.21
GoodRx Holdings (GDRX) United States $1.742B 45.70
Ryman Healthcare (RYHTY) New Zealand $1.658B 0.00
Teladoc Health (TDOC) United States $1.565B 0.00
Agilon Health (AGL) United States $1.273B 0.00
Pediatrix Medical (MD) United States $1.189B 11.63
CareDx (CDNA) United States $1.150B 0.00
Embecta (EMBC) United States $1.086B 7.59
AMN Healthcare Services Inc (AMN) United States $0.986B 6.67
Establishment Labs Holdings (ESTA) $0.968B 0.00
Auna S.A (AUNA) Luxembourg $0.624B 0.00
SBC Medicals (SBC) United States $0.518B 0.00
InnovAge Holding (INNV) United States $0.484B 0.00
Sonida Senior Living (SNDA) United States $0.429B 0.00
QDM (QDMI) Hong Kong, SAR China $0.426B 11.15
DocGo (DCGO) United States $0.426B 16.04
Enhabit (EHAB) United States $0.402B 34.74
MultiPlan (MPLN) United States $0.260B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.239B 0.00
Sera Prognostics (SERA) United States $0.217B 0.00
Beauty Health (SKIN) United States $0.216B 0.00
LifeMD (LFMD) United States $0.212B 0.00
Nutex Health (NUTX) United States $0.206B 0.00
Performant Healthcare (PHLT) United States $0.181B 0.00
Biodesix (BDSX) United States $0.167B 0.00
So-Young (SY) China $0.110B 18.60
ModivCare (MODV) United States $0.093B 5.03
Ascend Wellness Holdings (AAWH) United States $0.085B 0.00
IceCure Medical (ICCM) Israel $0.068B 0.00
NeueHealth (NEUE) United States $0.062B 1.63
Singular Genomics Systems (OMIC) United States $0.050B 0.00
Oncology Institute (TOI) United States $0.042B 0.00
OncoCyte (OCX) United States $0.035B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.032B 0.00
Co-Diagnostics (CODX) United States $0.025B 0.00
Pheton Holdings (PTHL) China $0.025B 0.00
KindlyMD (KDLY) United States $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
XWELL (XWEL) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
NewGenIvf Group (NIVF) Thailand $0.004B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
Aclarion (ACON) United States $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00